Authors:
GIBB RK
TAYLOR DD
WAN T
OCONNOR DM
DOERING DL
GERCELTAYLOR C
Citation: Rk. Gibb et al., APOPTOSIS AS A MEASURE OF CHEMOSENSITIVITY TO CISPLATIN AND TAXOL THERAPY IN OVARIAN-CANCER CELL-LINES, Gynecologic oncology, 65(1), 1997, pp. 13-22
Authors:
GERCELTAYLOR C
DOERING DL
KRAEMER FB
TAYLOR DD
Citation: C. Gerceltaylor et al., ABERRATIONS IN NORMAL SYSTEMIC LIPID-METABOLISM IN OVARIAN-CANCER PATIENTS, Gynecologic oncology, 60(1), 1996, pp. 35-41
Citation: Jl. Wittliff et al., EXPRESSION OF HEAT-SHOCK PROTEINS IN HUMAN BREAST, ENDOMETRIAL AND OVARIAN CARCINOMAS, Clinical chemistry, 42(6), 1996, pp. 687-687
Authors:
SANFILIPPO JS
MISELJIC S
YANG AR
DOERING DL
SHAHEEN RM
WITTLIFF JL
Citation: Js. Sanfilippo et al., QUANTITATIVE-ANALYSES OF EPIDERMAL GROWTH-FACTOR RECEPTORS, HER-2 NEUONCOPROTEIN AND CATHEPSIN-D IN NONMALIGNANT AND MALIGNANT UTERI/, Cancer, 77(4), 1996, pp. 710-716
Authors:
SHAHEEN RM
MISELJIC S
DOERING DL
WITTLIFF JL
Citation: Rm. Shaheen et al., COMPARISON OF CATHEPSIN-D DETERMINATIONS IN HUMAN CARCINOMAS BY ENZYME-IMMUNOASSAY AND IMMUNORADIOMETRIC ASSAY, Journal of clinical laboratory analysis, 9(6), 1995, pp. 351-358
Authors:
BOLLI JAN
DOERING DL
BOSSCHER JR
DAY TG
RAO CV
OWENS K
KELLY B
GOLDSMITH J
Citation: Jan. Bolli et al., SQUAMOUS-CELL CARCINOMA ANTIGEN - CLINICAL UTILITY IN SQUAMOUS-CELL CARCINOMA OF THE UTERINE CERVIX, Gynecologic oncology, 55(2), 1994, pp. 169-173